MRI-guided RFA therapy of liver and pancreatic tumors
Radiofrequency ablation (RFA) of liver and pancreatic tumors has been shown to be feasible and safe, but temperature feedback during the ablation procedure is currently lacking.read more
MRI-guided RFA therapy of liver and pancreatic tumorsRadiofrequency ablation (RFA) of liver and pancreatic tumors has been shown to be feasible and safe, but temperature feedback during the ablation procedure is currently lacking. Therefore, intraprocedural assessment of treatment efficacy is limited. Intraoperative MR imaging of RFA therapy could allow real-time monitoring of the ablation process and enable delineation of the true ablation zone during RFA therapy.
AimsOur research groups aims to assess the feasibility of real-time MRI temperature monitoring and ablation zone assessment during RFA of liver and pancreatic tumors.
DiscoveriesFirst preclinical tests is showing feasibility of RFA application in ex-vivo tissue with simultaneous MR thermometry imaging.
Research within MITeCBoth preclinical tests, as well as a first pilot study in patients (planned in the second half of 2018) will take place on the MITeC OR9 and MRI.
MITeC Connected operating rooms, for advancing innovation in patient care
MITeC offers unique consulting services and expertise to incorporate newly developed medical technology innovations and accelerate their success rate.read more